Pinc research has undertaken an analysis of the stock price of Cadila Healthcare and it is optimistic on the stock and has suggested a future price of Rs 751 for the stock. It has aksed its clients to accumulate the stock.
Cadila Healthcare’s (Cadila) stock price correction of 17 per cent in the last 6 months is unwarranted. Going ahead, analysts expect pick-up in the domestic business including Zydus Wellness (ZWL) which should help the company boost its margins. The Moraiya facility is expected to be cleared in H2FY13, leading to a flow of product approvals for the company. Overall, analysts estimate Cadila's revenues and net profit to clock a compounded growth of 16.3 per cent and 29.3 per cent respectively over FY12-14. Analysts expect operating margins to improve by 234bps over FY12-14 on the back of pick-up in sales, which in turn would negate the impact of increase in the interest cost.
Bookmark us for sure shot stock tips provider India and benefit from best technical analysis of stocks in India.
